Medizinische Universitätsklinik Bochum

www.medunikkh.de

Xaliproden Xalip C 02090 Studie geschlossen am 03.08.2009

Xalip C 02090 Studie geschlossen am 03.08.2009

"A multicenter, randomized, double blind, placebo controlled Phase III study to assess the efficacy of xaliproden in patients with oxaliplatin-induced peripheral sensory neuropathy (PSN) following adjuvant chemotherapy for colon cancer", as may be amended from time and is incorporated herein by reference.
Sponsering: Sanofi-Aventis

Ansprechpartner